Top

Published in:

01-03-2008 | Rapid Communication

Apparent extinction of non-G2 rotavirus strains from circulation in Recife, Brazil, after the introduction of rotavirus vaccine

Authors: T. Nakagomi, L. E. Cuevas, R. G. Gurgel, S. H. Elrokhsi, Y. A. Belkhir, M. Abugalia, W. Dove, F. M. U. Montenegro, J. B. Correia, O. Nakagomi, N. A. Cunliffe, C. A. Hart

Published in: Archives of Virology | Issue 3/2008

Abstract

The introduction of a G1P[8] rotavirus vaccine in Recife, Brazil, caused a decrease in rotavirus detection from 27% (March–May, 2006) to 5.0% (March–May, 2007), with all strains becoming G2, against which less protection had been predicted.

Araujo IT, Fialho AM, de Assis RM, M, Galvao M, Cruz CM, Ferreira MS, Leite JP (2002) Rotavirus strain diversity in Rio de Janeiro, Brazil: characterization of VP4 and VP7 genotypes in hospitalized children. J Trop Pediatr 48:214–218PubMedCrossRef

Bok K, Castagnaro N, Borsa A, Nates S, Espul C, Fay O, Fabri A, Grinstein S, Miceli I, Matson DO, Gomez JA (2001) Surveillance for rotavirus in Argentina. J Med Virol 65:190–198PubMedCrossRef

Castello A, Arvay M, Glass R, Gentsch J (2004) Rotavirus strain surveillance in Latin America: a review of the last nine years. Pediatr Infect Dis J 23(suppl):168–172CrossRef

Cunliffe NA, Nakagomi O (2005) A critical time for rotavirus vaccines: a review. Expert Rev Vaccines 4:521–532PubMedCrossRef

Estes MK, Kapikian AZ (2007) Rotavirus. In: Knipe DM, Howley PM (eds) Fields virology. 5th edn. vol 2. Lippincott Williams and Wilkins, Philadelphia, pp 1917–1974

Gentsch JR, Glass RI, Woods P, Gouvea V, Gorziglia M, Flores J, Das BK, Bhan MK (1992) Identification of group A rotavirus gene 4 types by polymerase chain reaction. J Clin Microbiol 30:1365–1373PubMed

Gouvea V, Glass RI, Woods P, Taniguchi K, Clark HF, Forreter B, Fang ZY (1990) Polymerase chain reaction amplification and typing of rotavirus nucleic acids from stool specimens. J Clin Microbiol 28:276–282PubMed

Kapikian AZ, Hoshino Y (2007) To serotype or not to serotype: that is still the question. J Infect Dis 195:625–632CrossRef

Kutsuzawa T, Konno T, Suzuki H, Kapikian AZ, Ebina T, Ishida N (1982) Isolation of human rotavirus subgroups 1 and 2 in cell culture. J Clin Microbiol 16:727–730PubMed

10.

Montenegro FM, Correia JB, Falbo AR, Dove W, Nakagomi T, Nakagomi O, Cuevas LE, Cunliffe NA, Hart CA (2007) Anticipating rotavirus vaccines in Brazil: detection and molecular characterization of emerging rotavirus serotypes G8 and G9 among children with diarrhea in Recife, Brazil. J Med Virol 79:335–340PubMedCrossRef

11.

Parashar UE, Gibson CJ, Bresee J, Glass R (2006) Rotavirus and severe childhood diarrhea. Emerg Infect Dis 12:304–306PubMed

12.

PATH’s Rotavirus Vaccine Program (2006) Accelerating the introduction of rotavirus vaccines into GAVI-eligible countries. http://www.gavialliance.org/resources/Rotavirus_Investment_Case_Oct06.pdf. Accessed 10 Oct 2007

13.

Ruiz-Palacios GM, Perez-Schael I, Velazquez FR, Abate H, Breuer T, Clemens SC, Cheuvart B, Espinoza F, Gillard P, Innis BL, Cervantes Y, Linhares AC, Lopez P, Macias-Parra M, Ortega-Barria E, Richardson V, Rivera-Medina DM, Rivera L, Salinas B, Pavia-Ruz N, Salmeron J, Ruttimann R, Tinoco JC, Rubio P, Nunez E, Guerrero ML, Yarzabal JP, Damaso S, Tornieporth N, Saez-Llorens X, Vergara RF, Vesikari T, Bouckenooghe A, Clemens R, De Vos B, O’Ryan M; Human Rotavirus Vaccine Study Group (2006) Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med 354:11–22PubMedCrossRef

14.

Vesikari T, Matson DO, Dennehy P, Van Damme P, Santosham M, Rodriguez Z, Dallas MJ, Heyse JF, Goveia MG, Black SB, Shinefield HR, Christie CD, Ylitalo S, Itzler RF, Coia ML, Onorato MT, Adeyi BA, Marshall GS, Gothefors L, Campens D, Karvonen A, Watt JP, O’Brien KL, DiNubile MJ, Clark HF, Boslego JW, Offit PA, Heaton PM; Rotavirus Efficacy, Safety Trial (REST) Study Team (2006) Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 354:23–33PubMedCrossRef

Title: Apparent extinction of non-G2 rotavirus strains from circulation in Recife, Brazil, after the introduction of rotavirus vaccine
Authors: T. Nakagomi
L. E. Cuevas
R. G. Gurgel
S. H. Elrokhsi
Y. A. Belkhir
M. Abugalia
W. Dove
F. M. U. Montenegro
J. B. Correia
O. Nakagomi
N. A. Cunliffe
C. A. Hart
Publication date: 01-03-2008
Publisher: Springer Vienna
Published in: Archives of Virology / Issue 3/2008
Print ISSN: 0304-8608
Electronic ISSN: 1432-8798
DOI: https://doi.org/10.1007/s00705-007-0028-z

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Apparent extinction of non-G2 rotavirus strains from circulation in Recife, Brazil, after the introduction of rotavirus vaccine

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2008

Identical rearrangement of NSP3 genes found in three independently isolated virus clones derived from mixed infection and multiple passages of Rotaviruses

Complete nucleotide sequence of a new potexvirus, “Phaius virus X”, isolated from Phaius flavus Lindl.

The complete nucleotide sequence of a novel Tobamovirus, Rehmannia mosaic virus

Characterization of a defective RNA derived from RNA 3 of the Y strain of cucumber mosaic virus

Pathogenesis of bovine spongiform encephalopathy in sheep

Biological and molecular characterization of tospoviruses in Thailand

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page